ASX - By Stock
|
RCE |
Re:
Ann: Ethics Approval Broadens to All Topical Infections
|
|
eieio
|
17 |
4.9K |
6 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
17
|
4.9K
|
6
|
|
ASX - By Stock
|
GGE |
GGE technicals
|
|
eieio
|
12 |
5.4K |
13 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
12
|
5.4K
|
13
|
|
ASX - By Stock
|
SNT |
Program trading on a roll
|
|
eieio
|
0 |
445 |
3 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
0
|
445
|
3
|
|
ASX - By Stock
|
MEI |
Re:
MEI chart
|
|
eieio
|
19 |
12K |
3 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
19
|
12K
|
3
|
|
ASX - By Stock
|
MEI |
Re:
MEI chart
|
|
eieio
|
19 |
12K |
3 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
19
|
12K
|
3
|
|
ASX - By Stock
|
MEI |
MEI chart
|
|
eieio
|
19 |
12K |
4 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
19
|
12K
|
4
|
|
ASX - By Stock
|
RDN |
Re:
Daily Discussion
|
|
eieio
|
9.4K |
4.0M |
10 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
9.4K
|
4.0M
|
10
|
|
ASX - By Stock
|
NGL |
Re:
NGL Chart
|
|
eieio
|
13 |
3.9K |
3 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
13
|
3.9K
|
3
|
|
ASX - By Stock
|
RDM |
Re:
Sybella Benchmarking vs Peers
|
|
eieio
|
164 |
63K |
1 |
17/03/24 |
17/03/24 |
ASX - By Stock
|
164
|
63K
|
1
|
|
ASX - By Stock
|
ADX |
Re:
Ann: Welchau Gas Exploration Well Update - Report No 1
|
|
eieio
|
12 |
6.0K |
4 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
12
|
6.0K
|
4
|
|
ASX - By Stock
|
NGL |
Re:
My Investment Thesis
|
|
eieio
|
30 |
8.9K |
3 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
30
|
8.9K
|
3
|
|
ASX - By Stock
|
IVR |
Re:
Precious Metals should be in demand NOW
|
|
eieio
|
338 |
93K |
1 |
30/12/23 |
30/12/23 |
ASX - By Stock
|
338
|
93K
|
1
|
|
ASX - By Stock
|
IVR |
Re:
Precious Metals should be in demand NOW
|
|
eieio
|
338 |
93K |
2 |
29/12/23 |
29/12/23 |
ASX - By Stock
|
338
|
93K
|
2
|
|
ASX - By Stock
|
NVO |
Re:
Ann: Investor Presentation
|
|
eieio
|
7 |
2.3K |
3 |
11/11/23 |
11/11/23 |
ASX - By Stock
|
7
|
2.3K
|
3
|
|
ASX - By Stock
|
ARV |
Greatland Gold on the move
|
|
eieio
|
2 |
1.7K |
0 |
07/11/23 |
07/11/23 |
ASX - By Stock
|
2
|
1.7K
|
0
|
|
ASX - By Stock
|
ARV |
Re:
Ann: Board and Management Changes
|
|
eieio
|
39 |
15K |
4 |
05/11/23 |
05/11/23 |
ASX - By Stock
|
39
|
15K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
eieio
|
18K |
7.1M |
8 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
18K
|
7.1M
|
8
|
|
Political Debate
|
|
Re:
Sad day for Australia
|
|
eieio
|
468 |
62K |
3 |
15/10/23 |
15/10/23 |
Political Debate
|
468
|
62K
|
3
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Nature Cancer Publishes Results of PXS Garvin Collaboration
|
|
eieio
|
18 |
7.8K |
0 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
18
|
7.8K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Nature Cancer Publishes Results of PXS Garvin Collaboration
|
|
eieio
|
18 |
7.8K |
0 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
18
|
7.8K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Nature Cancer Publishes Results of PXS Garvin Collaboration
|
|
eieio
|
18 |
7.8K |
1 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
18
|
7.8K
|
1
|
|
ASX - By Stock
|
ARV |
Unusual trading
|
|
eieio
|
71 |
28K |
3 |
19/06/23 |
19/06/23 |
ASX - By Stock
|
71
|
28K
|
3
|
|
ASX - By Stock
|
A4N |
Re:
Ann: Expansion of Synthetic Sapphire Glass Agreements with Ebner
|
|
eieio
|
7 |
2.9K |
0 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
7
|
2.9K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Becoming a substantial holder
|
|
eieio
|
87 |
49K |
4 |
03/05/23 |
03/05/23 |
ASX - By Stock
|
87
|
49K
|
4
|
|
ASX - By Stock
|
MTH |
Re:
Ann: Quarterly Activities Report and Appendix 5B
|
|
eieio
|
11 |
5.3K |
3 |
03/05/23 |
03/05/23 |
ASX - By Stock
|
11
|
5.3K
|
3
|
|
ASX - By Stock
|
FRX |
Re:
Ann: Flexiroam extends CEO's Employment Agreement
|
|
eieio
|
25 |
7.2K |
0 |
02/04/23 |
02/04/23 |
ASX - By Stock
|
25
|
7.2K
|
0
|
|
ASX - By Stock
|
FRX |
Re:
Ann: Response to ASX Price and Volume Query
|
|
eieio
|
15 |
4.7K |
0 |
02/03/23 |
02/03/23 |
ASX - By Stock
|
15
|
4.7K
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MESOBLAST CURES SR-aGVHD IN CHILDREN
|
|
eieio
|
81 |
37K |
36 |
23/02/23 |
23/02/23 |
ASX - By Stock
|
81
|
37K
|
36
|
|
ASX - By Stock
|
FRX |
Re:
Ann: Quarterly Update and Appendix 4C - December 2022
|
|
eieio
|
14 |
4.3K |
1 |
17/01/23 |
17/01/23 |
ASX - By Stock
|
14
|
4.3K
|
1
|
|
ASX - By Stock
|
FRX |
Re:
Ann: Quarterly Update and Appendix 4C - December 2022
|
|
eieio
|
14 |
4.3K |
0 |
17/01/23 |
17/01/23 |
ASX - By Stock
|
14
|
4.3K
|
0
|
|
ASX - By Stock
|
CLA |
Re:
Ann: Celsius obtains Social License to Operate for MCB Project
|
|
eieio
|
79 |
34K |
3 |
16/11/22 |
16/11/22 |
ASX - By Stock
|
79
|
34K
|
3
|
|
ASX - By Stock
|
CXO |
Re:
Banter and general comments
|
|
eieio
|
39K |
18M |
3 |
31/10/22 |
31/10/22 |
ASX - By Stock
|
39K
|
18M
|
3
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Becoming a substantial holder
|
|
eieio
|
8 |
2.6K |
0 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
8
|
2.6K
|
0
|
|
ASX - By Stock
|
FRX |
Re:
Ann: Investor Webinar Presentation Slides - Q2FY23 Update
|
|
eieio
|
5 |
2.1K |
1 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
5
|
2.1K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Placement
|
|
eieio
|
15 |
4.9K |
2 |
19/10/22 |
19/10/22 |
ASX - By Stock
|
15
|
4.9K
|
2
|
|
Charts
|
MSB |
Re:
MSB - Chart
|
|
eieio
|
248 |
107K |
13 |
08/10/22 |
08/10/22 |
Charts
|
248
|
107K
|
13
|
|
ASX - By Stock
|
XSO |
Re:
The Brains Trust-2022
|
|
eieio
|
2.5K |
489K |
4 |
29/08/22 |
29/08/22 |
ASX - By Stock
|
2.5K
|
489K
|
4
|
|
ASX - By Stock
|
CSS |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
eieio
|
8 |
4.2K |
0 |
26/08/22 |
26/08/22 |
ASX - By Stock
|
8
|
4.2K
|
0
|
|
ASX - By Stock
|
XSO |
Re:
The Brains Trust-2022
|
|
eieio
|
2.5K |
489K |
2 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
2.5K
|
489K
|
2
|
|
ASX - By Stock
|
XSO |
Re:
The Brains Trust-2022
|
|
eieio
|
2.5K |
489K |
3 |
13/06/22 |
13/06/22 |
ASX - By Stock
|
2.5K
|
489K
|
3
|
|
ASX - By Stock
|
GAL |
Re:
Ann: Rhodium in Drill Assays
|
|
eieio
|
200 |
107K |
1 |
29/05/22 |
29/05/22 |
ASX - By Stock
|
200
|
107K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Crohn’s Disease
|
|
eieio
|
150 |
55K |
8 |
08/05/22 |
08/05/22 |
ASX - By Stock
|
150
|
55K
|
8
|
|
ASX - By Stock
|
XSO |
Re:
The Brains Trust-2022
|
|
eieio
|
2.5K |
489K |
0 |
08/05/22 |
08/05/22 |
ASX - By Stock
|
2.5K
|
489K
|
0
|
|
ASX - By Stock
|
XSO |
Re:
The Brains Trust-2022
|
|
eieio
|
2.5K |
489K |
0 |
30/03/22 |
30/03/22 |
ASX - By Stock
|
2.5K
|
489K
|
0
|
|
Charts
|
PV1 |
Re:
GEV making a move
|
|
eieio
|
145 |
65K |
1 |
30/03/22 |
30/03/22 |
Charts
|
145
|
65K
|
1
|
|
ASX - By Stock
|
BRK |
Re:
Ann: First SWISH AOI Well Pays-Out in Record Time
|
|
eieio
|
161 |
49K |
0 |
29/03/22 |
29/03/22 |
ASX - By Stock
|
161
|
49K
|
0
|
|
ASX - By Stock
|
BRK |
Re:
Ann: First SWISH AOI Well Pays-Out in Record Time
|
|
eieio
|
161 |
49K |
2 |
29/03/22 |
29/03/22 |
ASX - By Stock
|
161
|
49K
|
2
|
|
ASX - By Stock
|
WEL |
Re:
Ann: High Margin Oil Production in a High Oil Price Environment
|
|
eieio
|
4 |
2.0K |
2 |
18/03/22 |
18/03/22 |
ASX - By Stock
|
4
|
2.0K
|
2
|
|
ASX - By Stock
|
WEL |
Re:
Ann: Operations Update
|
|
eieio
|
62 |
17K |
1 |
14/03/22 |
14/03/22 |
ASX - By Stock
|
62
|
17K
|
1
|
|
ASX - By Stock
|
WEL |
Re:
Ann: Operations Update
|
|
eieio
|
62 |
17K |
2 |
14/03/22 |
14/03/22 |
ASX - By Stock
|
62
|
17K
|
2
|
|